An interventional study of Electroacupuncture and Conventional physical therapy program in Stroke, sponsored by Ahmed Alshimy. Completed at 1 site in Egypt. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Ahmed Alshimy · Not applicable, Interventional, and Treatment
Improvement in pain and range of motion (ROM) outcomes for stroke cases suffering from complex regional pain syndrome (CRPS) can be attained through Electro-acupuncture therapy, which in turn improve functional independence and reduces financial strain on both patients and their families.
Group A received three sessions weekly of selected physical therapy program and electroacupuncture therapy, while Group B received the same selected physical therapy program alone. The Visual Analogue Scale (VAS) was used to assess pain, the Kinovea-based measurement was used to evaluate shoulder flexion ROM; and the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH)-Arabic version was used to assess functional independence.
7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.
This study's enrollment of 40 is below the median of 50 across 5,482 interventional studies indexed under Stroke.
Browse Stroke studies →Ahmed Alshimy is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Consisted of 20 patients who received a selected physical therapy program and electroacupuncture. The treatment was conducted for four weeks, three sessions weekly for 12 sessions
Other: Electroacupuncture · Other: Conventional physical therapy program
Consisted of 20 cases who received the same selected physical therapy program only, for four weeks, three sessions weekly for 12 sessions.
Other: Conventional physical therapy program
Sterile, single-use stainless-steel acupuncture needles (0.25 × 30 mm) were inserted at six acupoints on the affected side: TE14., SI9., and GB21(shoulder region); LI11 and TE5 (elbow and forearm); and TE2 (dorsum of the hand)
(1) passive and active-assisted range of motion exercises (5-10 repetitions per movement, 10-15 second holds) (2) desensitization techniques using graded textures (cotton, sponge, Velcro, toothbrush), progressing from light touch to deep pressure, combined with contrast baths (3) therapeutic exercises, beginning with isometric strengthening and progressing to isotonic exercises as tolerated, followed by functional task-based activities targeting coordination and strength; (4) a structured stress-loading program involving active movement and joint compression, including quadruped scrubbing with the affected hand (5) heat therapy using hot packs for pain relief and (6) graded motor imagery, progressing through laterality training, explicit motor imagery, and mirror visual feedback. Each session began with a 5-minute warm-up and ended with a 5-minute cool-down.
Visual analogue scale
Subjective pain assessment
Time frame: 4 weeks
Kinovea-based measurement for shoulder flexion
Shoulder flexion range of motion (ROM) assessment was conducted using Kinovea-2020 software following a standardized protocol
Time frame: 4 weeks
Arabic version of DASH questionnaire
Designed to quantify functional limitations and symptoms affecting the arm, shoulder, and hand region
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ahmed Alshimy